Literature DB >> 10628152

Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure.

A S Hail1, C A Rossi, G V Ludwig, B E Ivins, R F Tammariello, E A Henchal.   

Abstract

Bacillus anthracis, a spore-forming bacterium, is the etiologic agent of anthrax. B. anthracis spores can be aerosolized, are relatively easy to produce, and are capable of producing high mortality when inhaled. The prompt use of postexposure antibiotics combined with vaccination greatly increases the survival rate. Rapid detection of exposure is critical to effective case management. Using common collection swabs, culture medium, and culturing equipment, we compared six different noninvasive sampling sites to determine which might best be used to rapidly detect the presence of B. anthracis spores on rhesus monkeys after aerosolization. The results indicate that the greatest number of spores were deposited in the nares, on the face, and on the haired portions of the head, suggesting that these locations are the most effective sampling sites when attempting to detect B. anthracis aerosol exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10628152

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  5 in total

1.  Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax.

Authors:  Cynthia A Rossi; Melanie Ulrich; Sarah Norris; Douglas S Reed; Louise M Pitt; Elizabeth K Leffel
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

2.  Large-scale screening of nasal swabs for Bacillus anthracis: descriptive summary and discussion of the National Institutes of Health's experience.

Authors:  Pattarachai Kiratisin; Caroline D Fukuda; Alexandra Wong; Frida Stock; Jeanne C Preuss; Laura Ediger; Trupti N Brahmbhatt; Steven H Fischer; Daniel P Fedorko; Frank G Witebsky; Vee J Gill
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 3.  The evolving field of biodefence: therapeutic developments and diagnostics.

Authors:  James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

4.  Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response.

Authors:  Vincent P Hsu; Susan L Lukacs; Thomas Handzel; James Hayslett; Scott Harper; Thomas Hales; Vera A Semenova; Sandra Romero-Steiner; Cheryl Elie; Conrad P Quinn; Rima Khabbaz; Ali S Khan; Gregory Martin; John Eisold; Anne Schuchat; Rana A Hajjeh
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

5.  First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001.

Authors:  Marc S Traeger; Steven T Wiersma; Nancy E Rosenstein; Jean M Malecki; Colin W Shepard; Pratima L Raghunathan; Segaran P Pillai; Tanja Popovic; Conrad P Quinn; Richard F Meyer; Sharif R Zaki; Savita Kumar; Sherrie M Bruce; James J Sejvar; Peter M Dull; Bruce C Tierney; Joshua D Jones; Bradley A Perkins
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.